CXCR5 and systemic lupus erythematosus: Serum CXCL13 has high accuracy in the diagnosis of SLE, and circulating CXCR5+ T cells may serve as a novel biomarker for the diagnosis of SLE and LN, which might complement the poor performance of serum CXCL13 in the diagnostic efficacy of LN.